How a virtual medical cannabis clinic is working on healthcare coverage for THC

A virtual medical cannabis clinic is developing strategies to expand healthcare coverage for THC-containing products, addressing a significant barrier to patient access since most insurance plans do not cover cannabis despite its FDA approval for specific indications and growing clinical use. The clinic’s efforts to work with insurers represent an important shift in recognizing cannabis as a legitimate therapeutic option rather than solely a controlled substance, potentially improving affordability and accessibility for patients who might otherwise forgo treatment or face substantial out-of-pocket costs. By documenting clinical outcomes and building evidence of medical necessity, the clinic aims to establish precedent for insurance reimbursement that could influence broader coverage policies across payers and jurisdictions. This development is particularly relevant for clinicians treating patients with conditions like chemotherapy-induced nausea, chronic pain, or epilepsy, where cannabis may offer therapeutic benefit but cost prohibits use. Clinicians should be aware that coverage landscapes are evolving and should advocate for their patients by documenting medical rationale and exploring emerging insurance options when recommending cannabis-based therapies.

💬 Join the Conversation

Have a question about how this applies to your situation? Ask Dr. Caplan →

Want to discuss this topic with other patients and caregivers? Join the forum discussion →

Have thoughts on this? Share it:

• CBN launches supervisory pilot to tackle virtual asset risks – Businessday NG
• CED Digest: 230 Items — March 18, 2026
• CED Digest: 239 Items — March 17, 2026